AI assistant
Sending…
WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2025
May 8, 2025
30339_dirs_2025-05-08_0f80562a-cebc-4209-8821-f629f29c63ff.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2025-05-06
Reporting Person: Joseph Molly (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-05-06 | Common Stock | A | 1071 | — | Acquired | 2884.44 | Direct |
Footnotes
F1: These shares of restricted stock units will vest in full on the date of the next annual shareholder meeting.
More from WEST PHARMACEUTICAL SERVICES INC
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 5
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Interim / Quarterly Report
2026
Apr 23
Regulatory Filings
2026
Apr 23
Major Shareholding Notification
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 12